SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 21, 2004
Specialty Laboratories, Inc.
(Exact name of registrant as specified in charter)
|
California |
|
001-16217 |
|
95-2961036 |
|
(State or other
jurisdiction |
|
(Commission |
|
(IRS Employer |
|
|
||||
|
2211 Michigan Avenue, Santa Monica, California |
|
90404 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
Registrant’s telephone number, including area code (310) 828-6543
(Former name or former address, if changed since last report.)
|
ITEM 7 |
|
|
|
FINANCIAL STATEMENTS AND EXHIBITS |
|
|
|
|
|
|
|
(c) |
|
Exhibits |
|
The following document is filed as an exhibit to this report: |
|
|
|
|
|
|
|
|
|
99.1 |
|
Press Release dated July 21, 2004. |
ITEM 9 REGULATION FD DISCLOSURE
ITEM 12 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On July 21, 2004, Specialty Laboratories, Inc., (the “Registrant”) announced financial results for the second quarter ended June 30, 2004. A copy of the press release issued by the Registrant on July 21, 2004 concerning the foregoing matter is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
Specialty Laboratories, Inc. |
||
|
|
|
||
|
|
|
||
|
Date: July 21, 2004 |
By: |
/s/ Kevin R. Sayer |
|
|
|
|
Kevin R. Sayer, |
|
|
|
|
Chief Financial Officer |
|
3
EXHIBIT INDEX
The following document is filed as an exhibit to this report:
|
Exhibits |
|
|
|
|
|
|
|
99.1 |
|
Press Release dated July 21, 2004. |
4